What Do EEG Foundation Models Capture from Human Brain Signals?

Pretrained EEG foundation models are proposed for clinical decoding, but whether reported gains transfer across populations or survive negative controls is unclear. We benchmark LaBraM, EEGMamba, CBraMod, REVE, LEAD, BENDR, and BIOT on five clinical tasks across four datasets. Primary analyses use frozen linear probes with subject-disjoint LOSO or grouped five-fold validation. Because CAUEEG releases no patient identifiers, it is evaluated at recording level with a patient-disjoint sensitivity. We challenge apparent gains using stronger classical comparators, label permutation, scrambled-label fine-tuning, and random-initialisation controls. In a matched 19-channel CAUEEG evaluation (Normal/MCI/Dementia; N = 1,187 recordings), classical features achieve 0.734 macro-AUROC versus 0.699 for BIOT, 0.669 for CBraMod, and 0.568 for REVE. A patient-disjoint sensitivity retains the classical-over-REVE ordering (0.717 versus 0.565). Dataset identity is decoded from frozen REVE embeddings at or near ceiling across Western-Korean and Western-Western pairs, including after PCA-50 and removal of line-frequency and amplitude-scale information. This establishes dataset membership, not a causal site or population effect. A matched random-initialised encoder exceeds pretrained REVE on CAUEEG (0.659 versus 0.570). On CHB-MIT cross-subject ictal detection (n = 23), REVE reaches 0.793, versus 0.739 for the best enhanced nonlinear comparator, 0.701 for random initialisation, and 0.505 for raw-signal random features. Because preprocessing removes absolute amplitude, this does not establish superiority over every plausible handcrafted baseline. Conclusions change materially after montage matching, patient-overlap checks, stronger comparators, and representation controls. We distill these checks into a reporting protocol for clinical EEG foundation-model studies.

Foundation models (FMs) promise to extract unified representations that generalize across downstream tasks. They have emerged across fields, including electroencephalography (EEG), but it is less clear how effective they are in this particular field. Published evaluations differ in datasets, in the EEG-specific preprocessing that might influence reported results, and in the reported metrics, frequently obscuring the clinical relevance in EEG. We introduce NeuroAtlas, the largest EEG benchmark to date: 42 datasets and 260k hours covering clinical EEG (epilepsy, sleep medicine, brain age estimation) and brain-computer interfaces, and include multiple datasets per task along with bespoke clinical evaluation metrics. Besides evaluating EEG-FMs with respect to supervised baselines, we present results from generic time-series FMs. We report three findings. First, EEG-specific FMs do not consistently outperform time-series FMs, which have neither EEG-focused architectures nor been pretrained on EEG. Second, standard machine learning metrics are insufficient to assess clinical utility: thus, we thoroughly evaluate more appropriate measures such as the quality of event-level decision-making, hypnogram-derived features, and the brain-age gap in the domains of epilepsy, sleep, and brain age, respectively. Third, model rankings and performance can vary substantially within domains. We conclude that pretrained models perform largely on par, with only narrow advantages for a few, and that current models do not yet deliver on the promise of an out-of-the-box unified EEG model. NeuroAtlas exposes this gap and provides the datasets and metrics for the next generation of unified EEG FMs.

Clinical EEG interpretation requires reasoning over full EEG sessions and integrating signal patterns with clinical context. Existing EEG foundation models are largely designed for short-window decoding and do not incorporate clinical context. We introduce CLEF, a clinically grounded long-context EEG foundation model. CLEF represents EEG sessions as 3D multitaper spectrogram tokens, enabling tractable Transformer modeling at session scale, and aligns embeddings with neurologist reports and structured EHR data through contrastive objectives. We evaluate CLEF on a new 234-task benchmark spanning disease phenotypes, medication exposures, and EEG findings, with more than 260k EEG sessions from over 108k patients. CLEF outperforms prior EEG foundation models on 229 of 234 tasks, improving mean AUROC from 0.65 to 0.74. Reconstruction-only pretraining surpasses prior EEG foundation models, while report and EHR alignment yields further gains. Held-out concept and external-cohort experiments suggest that these representations transfer beyond observed alignment targets. These results support session-scale, clinically grounded representation learning as a promising foundation-model paradigm for clinical EEG.